Mezochow A, Thakur K, Zentner I, Subbian S, Kagan L, Vinnard C
Int J Infect Dis. 2019; 84:15-21.
PMID: 31051278
PMC: 6666413.
DOI: 10.1016/j.ijid.2019.04.026.
Abulfathi A, Decloedt E, Svensson E, Diacon A, Donald P, Reuter H
Clin Pharmacokinet. 2019; 58(9):1103-1129.
PMID: 31049868
DOI: 10.1007/s40262-019-00764-2.
Dian S, Yunivita V, Ganiem A, Pramaesya T, Chaidir L, Wahyudi K
Antimicrob Agents Chemother. 2018; 62(12).
PMID: 30224533
PMC: 6256787.
DOI: 10.1128/AAC.01014-18.
Mezochow A, Thakur K, Vinnard C
Curr Neurol Neurosci Rep. 2017; 17(11):85.
PMID: 28932979
PMC: 5729589.
DOI: 10.1007/s11910-017-0796-0.
Nau R, Sorgel F, Eiffert H
Clin Microbiol Rev. 2010; 23(4):858-83.
PMID: 20930076
PMC: 2952976.
DOI: 10.1128/CMR.00007-10.
Rifampin for therapy of experimental pneumococcal meningitis in rabbits.
Nau R, Kaye K, Sachdeva M, Sande E, Tauber M
Antimicrob Agents Chemother. 1994; 38(5):1186-9.
PMID: 8067762
PMC: 188176.
DOI: 10.1128/AAC.38.5.1186.
Antibiotic therapy of experimental Staphylococcus epidermidis endocarditis.
Vazquez G, Archer G
Antimicrob Agents Chemother. 1980; 17(2):280-5.
PMID: 7387148
PMC: 283772.
DOI: 10.1128/AAC.17.2.280.
In vitro activity of rifampin in combination with oxacillin against Staphylococcus aureus.
Maduri Traczewski M, Goldmann D, Murphy P
Antimicrob Agents Chemother. 1983; 23(4):571-6.
PMID: 6859835
PMC: 184703.
DOI: 10.1128/AAC.23.4.571.
Antibiotic susceptibility and synergy of clinical isolates of Listeria monocytogenes.
Tuazon C, Shamsuddin D, Miller H
Antimicrob Agents Chemother. 1982; 21(3):525-7.
PMID: 6808911
PMC: 181930.
DOI: 10.1128/AAC.21.3.525.
Rifampicin in tuberculous meningitis: a retrospective assessment.
Latorre P, Gallofre M, Laporte J, Massons J
Eur J Clin Pharmacol. 1984; 26(5):583-6.
PMID: 6468472
DOI: 10.1007/BF00543489.
Cerebrospinal fluid pharmacokinetics of the antituberculosis drugs.
Holdiness M
Clin Pharmacokinet. 1985; 10(6):532-4.
PMID: 4064452
DOI: 10.2165/00003088-198510060-00006.
Tuberculosis of the nervous system: a modern problem.
Tang L, Swash M
J R Soc Med. 1985; 78(6):429-32.
PMID: 3999076
PMC: 1289768.
DOI: 10.1177/014107688507800601.
CNS tuberculosis.
Sheller J, DES PREZ R
Neurol Clin. 1986; 4(1):143-58.
PMID: 3523199
PMC: 7134635.
Tuberculous meningitis--clinical and laboratory review of 100 patients.
Kilpatrick M, Girgis N, Yassin M, Abu el Ella A
J Hyg (Lond). 1986; 96(2):231-8.
PMID: 3084628
PMC: 2129657.
DOI: 10.1017/s0022172400066006.
In vitro interaction between rifampin and clindamycin against pathogenic coagulase-negative staphylococci.
Arditi M, Yogev R
Antimicrob Agents Chemother. 1989; 33(2):245-7.
PMID: 2719468
PMC: 171467.
DOI: 10.1128/AAC.33.2.245.
Pharmacokinetics, cerebrospinal fluid concentration, and safety of intravenous rifampin in pediatric patients undergoing shunt placements.
Nahata M, Fan-Havard P, Barson W, Bartkowski H, Kosnik E
Eur J Clin Pharmacol. 1990; 38(5):515-7.
PMID: 2379538
DOI: 10.1007/BF02336694.
The management of tuberculous meningitis.
Humphries M
Thorax. 1992; 47(8):577-81.
PMID: 1412110
PMC: 463911.
DOI: 10.1136/thx.47.8.577.
Rifamycin in neonatal flavobacteria meningitis.
Lee E, Robinson M, Thong M, Puthucheary S
Arch Dis Child. 1976; 51(3):209-13.
PMID: 952554
PMC: 1545921.
DOI: 10.1136/adc.51.3.209.
Tuberculous meningitis in children: a retrospective study of 79 patients, with an analysis of prognostic factors.
Delage G, Dusseault M
Can Med Assoc J. 1979; 120(3):305-9.
PMID: 427668
PMC: 1819003.